STUDY_ID	SITE_ID	SUBJ_ID	SAMPLE_ID	PLATFORM	TISSUETYPE	ATTR1	ATTR2	CATEGORY_CD	SOURCE_CD
GSE31652		GSM785971	GSM785971	GPL571	Patient: 1207, Dosage: 150 mg, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785972	GSM785972	GPL571	Patient: 1207, Dosage: 150 mg, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785973	GSM785973	GPL571	Patient: 1208, Dosage: 150 mg, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785974	GSM785974	GPL571	Patient: 1208, Dosage: 150 mg, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785975	GSM785975	GPL571	Patient: 1209, Dosage: 150 mg, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785976	GSM785976	GPL571	Patient: 1209, Dosage: 150 mg, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785977	GSM785977	GPL571	Patient: 1610, Dosage: 150 mg, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785978	GSM785978	GPL571	Patient: 1610, Dosage: 150 mg, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785979	GSM785979	GPL571	Patient: 1611, Dosage: 150 mg, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785980	GSM785980	GPL571	Patient: 1615, Dosage: 150 mg, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785981	GSM785981	GPL571	Patient: 1615, Dosage: 150 mg, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785982	GSM785982	GPL571	Patient: 1710, Dosage: 150 mg, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785983	GSM785983	GPL571	Patient: 1710, Dosage: 150 mg, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785984	GSM785984	GPL571	Patient: 1803, Dosage: 150 mg, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785985	GSM785985	GPL571	Patient: 1108, Dosage: Placebo, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785986	GSM785986	GPL571	Patient: 1108, Dosage: Placebo, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785987	GSM785987	GPL571	Patient: 1304, Dosage: Placebo, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785988	GSM785988	GPL571	Patient: 1405, Dosage: Placebo, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785989	GSM785989	GPL571	Patient: 1405, Dosage: Placebo, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785990	GSM785990	GPL571	Patient: 1503, Dosage: Placebo, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785991	GSM785991	GPL571	Patient: 1503, Dosage: Placebo, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785992	GSM785992	GPL571	Patient: 1507, Dosage: Placebo, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785993	GSM785993	GPL571	Patient: 1507, Dosage: Placebo, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785994	GSM785994	GPL571	Patient: 1613, Dosage: Placebo, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785995	GSM785995	GPL571	Patient: 1613, Dosage: Placebo, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785996	GSM785996	GPL571	Patient: 1614, Dosage: Placebo, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785997	GSM785997	GPL571	Patient: 1614, Dosage: Placebo, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785998	GSM785998	GPL571	Patient: 1702, Dosage: Placebo, Time: Week 0	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM785999	GSM785999	GPL571	Patient: 1702, Dosage: Placebo, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD
GSE31652		GSM786000	GSM786000	GPL571	Patient: 1704, Dosage: Placebo, Time: Week 2	Homo sapiens		Biomarker_Data+PLATFORM+ATTR1	STD